市場調查報告書
商品編碼
1387497
多形性膠質母細胞瘤 (GBMF) 市場報告:2030 年趨勢、預測和競爭分析Glioblastoma Multiforme Market Report: Trends, Forecast and Competitive Analysis to 2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
多形性膠質母細胞瘤(GBMF)的趨勢和預測
預計到 2030 年,全球多形性膠質母細胞瘤 (GBMF) 市場預計將達到 12 億美元,2024 年至 2030 年年複合成長率為 8.2%。市場的主要促進因素是研發費用不斷上升、多形性膠質母細胞瘤(GBMF)盛行率不斷上升、有利的法規環境以及腦腫瘤盛行率不斷上升以及強大的產品平臺。全球多形性膠質母細胞瘤 (GBMF) 市場的未來前景看好,醫院、診所和門診手術中心市場存在商機。
多形性膠質母細胞瘤 (GBMF) 市場洞察
Lucintel 預測,由於放射線治療的效率和對復發性腦腫瘤病例的強大支持,以及放射技術的進步和生存率的提高,放射治療在預測期內將繼續成為最大的細分市場。
由於政府對醫療保健產業發展的支持、對罕見疾病的廣泛認知、優質醫療設施的便利性以及有利的報銷政策,北美在預測期內可能仍是最大的地區。
Glioblastoma Multiforme Trends and Forecast
The future of the global glioblastoma multiforme market looks promising with opportunities in the hospitals, clinics, and ambulatory surgical centers markets. The global glioblastoma multiforme market is expected to reach an estimated $1.2 billion by 2030 with a CAGR of 8.2% from 2024 to 2030. The major drivers for this market are rising R&D costs, expanding glioblastoma multiforme prevalence, and advantageous regulatory environments, as well as, growing prevalence of brain cancers and having a robust product pipeline.
A more than 150-page report is developed to help in your business decisions.
Glioblastoma Multiforme by Segment
The study includes a forecast for the global glioblastoma multiforme by treatment, drug, end use, and region.
Glioblastoma Multiforme Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:
Glioblastoma Multiforme Market by Drug [Shipment Analysis by Value from 2018 to 2030]:
Glioblastoma Multiforme Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
Glioblastoma Multiforme Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Glioblastoma Multiforme Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies glioblastoma multiforme companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the glioblastoma multiforme companies profiled in this report include-
Glioblastoma Multiforme Market Insights
Lucintel forecasts that radiation therapy will remain the largest segment over the forecast period because it is efficient and strongly endorsed for recurring cases of brain tumors, as well as, advancements in radiation technology and increased survival rates.
North America will remain the largest region over the forecast period due to government backing for healthcare sector advancement, widespread awareness regarding rare disorders, convenient access to high-quality medical institutions, and favorable reimbursement policies in this region.
Features of the Global Glioblastoma Multiforme Market
Market Size Estimates: Glioblastoma multiforme market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Glioblastoma multiforme market size by treatment, drug, end use, and region in terms of value ($B).
Regional Analysis: Glioblastoma multiforme market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different treatment, drug, end use, and regions for the glioblastoma multiforme market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the glioblastoma multiforme market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the glioblastoma multiforme market size?
Answer: The global glioblastoma multiforme market is expected to reach an estimated $1.2 billion by 2030.
Q2. What is the growth forecast for glioblastoma multiforme market?
Answer: The global glioblastoma multiforme market is expected to grow with a CAGR of 8.2% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the glioblastoma multiforme market?
Answer: The major drivers for this market are rising R&D costs, expanding glioblastoma multiforme prevalence, and advantageous regulatory environments, as well as, growing prevalence of brain cancers and having a robust product pipeline.
Q4. What are the major segments for glioblastoma multiforme market?
Answer: The future of the global glioblastoma multiforme market looks promising with opportunities in the hospitals, clinics, and ambulatory surgical centers markets.
Q5. Who are the key glioblastoma multiforme market companies?
Answer: Some of the key glioblastoma multiforme companies are as follows:
Q6. Which glioblastoma multiforme market segment will be the largest in future?
Answer: Lucintel forecasts that radiation therapy will remain the largest segment over the forecast period because it is efficient and strongly endorsed for recurring cases of brain tumors, as well as, advancements in radiation technology and increased survival rates.
Q7. In glioblastoma multiforme market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to government backing for healthcare sector advancement, widespread awareness regarding rare disorders, convenient access to high-quality medical institutions, and favorable reimbursement policies in this region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.